Cargando…

Changes in electrophysiological markers of cognitive control after administration of galantamine

The healthy brain is able to maintain a stable balance between bottom-up sensory processing and top-down cognitive control. The neurotransmitter acetylcholine plays a substantial role in this. Disruption of this balance could contribute to symptoms occurring in psychosis, including subtle disruption...

Descripción completa

Detalles Bibliográficos
Autores principales: Gascoyne, Lauren E., Mullinger, Karen J., Robson, Siân E., Kumar, Jyothika, O'Neill, George C., Palaniyappan, Lena, Morris, Peter G., Liddle, Elizabeth B., Brookes, Matthew J., Liddle, Peter F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078055/
https://www.ncbi.nlm.nih.gov/pubmed/30090697
http://dx.doi.org/10.1016/j.nicl.2018.07.019
_version_ 1783345026716139520
author Gascoyne, Lauren E.
Mullinger, Karen J.
Robson, Siân E.
Kumar, Jyothika
O'Neill, George C.
Palaniyappan, Lena
Morris, Peter G.
Liddle, Elizabeth B.
Brookes, Matthew J.
Liddle, Peter F.
author_facet Gascoyne, Lauren E.
Mullinger, Karen J.
Robson, Siân E.
Kumar, Jyothika
O'Neill, George C.
Palaniyappan, Lena
Morris, Peter G.
Liddle, Elizabeth B.
Brookes, Matthew J.
Liddle, Peter F.
author_sort Gascoyne, Lauren E.
collection PubMed
description The healthy brain is able to maintain a stable balance between bottom-up sensory processing and top-down cognitive control. The neurotransmitter acetylcholine plays a substantial role in this. Disruption of this balance could contribute to symptoms occurring in psychosis, including subtle disruption of motor control and aberrant appropriation of salience to external stimuli; however the pathological mechanisms are poorly understood. On account of the role beta oscillations play in mediating cognitive control, investigation of beta oscillations is potentially informative about such mechanisms. Here, we used magnetoencephalography to investigate the effect of the acetylcholinesterase-inhibitor, galantamine, on beta oscillations within the sensorimotor region during both a sensorimotor task and a relevance–modulation task in healthy participants, employing a double blind randomized placebo controlled cross-over design. In the galantamine condition, we found a significant reduction in the post-movement beta rebound in the case of executed movements and also in a planned but not executed movement. In the latter case, the effect was significantly greater following task-relevant compared with irrelevant stimuli. The results suggest that the action of galantamine reduces the influence of top-down cognitive processing relative to bottom-up perceptual processing in a manner resembling changes previously reported in schizophrenia.
format Online
Article
Text
id pubmed-6078055
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60780552018-08-08 Changes in electrophysiological markers of cognitive control after administration of galantamine Gascoyne, Lauren E. Mullinger, Karen J. Robson, Siân E. Kumar, Jyothika O'Neill, George C. Palaniyappan, Lena Morris, Peter G. Liddle, Elizabeth B. Brookes, Matthew J. Liddle, Peter F. Neuroimage Clin Regular Article The healthy brain is able to maintain a stable balance between bottom-up sensory processing and top-down cognitive control. The neurotransmitter acetylcholine plays a substantial role in this. Disruption of this balance could contribute to symptoms occurring in psychosis, including subtle disruption of motor control and aberrant appropriation of salience to external stimuli; however the pathological mechanisms are poorly understood. On account of the role beta oscillations play in mediating cognitive control, investigation of beta oscillations is potentially informative about such mechanisms. Here, we used magnetoencephalography to investigate the effect of the acetylcholinesterase-inhibitor, galantamine, on beta oscillations within the sensorimotor region during both a sensorimotor task and a relevance–modulation task in healthy participants, employing a double blind randomized placebo controlled cross-over design. In the galantamine condition, we found a significant reduction in the post-movement beta rebound in the case of executed movements and also in a planned but not executed movement. In the latter case, the effect was significantly greater following task-relevant compared with irrelevant stimuli. The results suggest that the action of galantamine reduces the influence of top-down cognitive processing relative to bottom-up perceptual processing in a manner resembling changes previously reported in schizophrenia. Elsevier 2018-07-23 /pmc/articles/PMC6078055/ /pubmed/30090697 http://dx.doi.org/10.1016/j.nicl.2018.07.019 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Gascoyne, Lauren E.
Mullinger, Karen J.
Robson, Siân E.
Kumar, Jyothika
O'Neill, George C.
Palaniyappan, Lena
Morris, Peter G.
Liddle, Elizabeth B.
Brookes, Matthew J.
Liddle, Peter F.
Changes in electrophysiological markers of cognitive control after administration of galantamine
title Changes in electrophysiological markers of cognitive control after administration of galantamine
title_full Changes in electrophysiological markers of cognitive control after administration of galantamine
title_fullStr Changes in electrophysiological markers of cognitive control after administration of galantamine
title_full_unstemmed Changes in electrophysiological markers of cognitive control after administration of galantamine
title_short Changes in electrophysiological markers of cognitive control after administration of galantamine
title_sort changes in electrophysiological markers of cognitive control after administration of galantamine
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078055/
https://www.ncbi.nlm.nih.gov/pubmed/30090697
http://dx.doi.org/10.1016/j.nicl.2018.07.019
work_keys_str_mv AT gascoynelaurene changesinelectrophysiologicalmarkersofcognitivecontrolafteradministrationofgalantamine
AT mullingerkarenj changesinelectrophysiologicalmarkersofcognitivecontrolafteradministrationofgalantamine
AT robsonsiane changesinelectrophysiologicalmarkersofcognitivecontrolafteradministrationofgalantamine
AT kumarjyothika changesinelectrophysiologicalmarkersofcognitivecontrolafteradministrationofgalantamine
AT oneillgeorgec changesinelectrophysiologicalmarkersofcognitivecontrolafteradministrationofgalantamine
AT palaniyappanlena changesinelectrophysiologicalmarkersofcognitivecontrolafteradministrationofgalantamine
AT morrispeterg changesinelectrophysiologicalmarkersofcognitivecontrolafteradministrationofgalantamine
AT liddleelizabethb changesinelectrophysiologicalmarkersofcognitivecontrolafteradministrationofgalantamine
AT brookesmatthewj changesinelectrophysiologicalmarkersofcognitivecontrolafteradministrationofgalantamine
AT liddlepeterf changesinelectrophysiologicalmarkersofcognitivecontrolafteradministrationofgalantamine